LAS VEGAS, NV--(Marketwired - Sep 22, 2016) - StereoVision Entertainment Inc., a publicly traded Nevada corporation ( OTC PINK : SVSN ), announced today that their jointly owned subsidiary GreenVision Systems, a Puerto Rico medical cannabis company, has signed Mentor Capital, Inc. ( OTCQB : MNTR ) to advise on financing and optimizing GreenVision's rapid growth in Puerto Rico's emerging medical cannabis market. GreenVision is financing its start-up with a convertible debenture for StereoVision's publicly traded stock. This first round will be directed to licensing costs for cannabis cultivation, manufacturing, and transportation in Puerto Rico, and GreenVision's filing an S-1 registration statement with the SEC. For details, accredited investors can contact email@example.com.
StereoVision Entertainment Inc. (http://stereovision.com) Headquartered in Las Vegas, StereoVision (SVE) is a publicly traded Nevada corporation ( OTC PINK : SVSN ) focused on creating, acquiring, and producing multimedia content, and the medical marijuana and hemp industries. SVE is generating a variety of Intellectual properties and technologies for the many existing and emerging content distribution platforms, and SVE is pursuing the legal cultivation, manufacturing, and transportation of medical cannabis products in Puerto Rico, a state of the art medical cannabis facility in Puerto Rico and hemp farming export business through our jointly owned Puerto Rico subsidiary GreenVision Systems.
Mentor Capital Inc. (http://mentorcapital.com) Based in San Diego, Mentor Capital Inc. is a publicly operating company that acquires and/or provides liquidity for medical and recreational use cannabis companies. Mentor's preferred focus is medical cannabis and Mentor seeks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson's disease, glaucoma, and blunting chronic pain.
Safe harbor Statement: Except for historical information, this news release may contain "Forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 as amended.